#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Complex regional pain syndrome Primary adrenal insufficiency Cervix carcinoma recurrent Pulmonary sarcoidosis Chondrosarcoma metastatic Osteopetrosis Congenital cystic kidney disease Gestational trophoblastic tumour Mastocytosis Anaemia Hydrocephalus Metastatic malignant melanoma Neuroendocrine carcinoma metastatic Ovarian epithelial cancer Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Treatment Congenital hypotransferrinaemia – Diagnostics Pleural mesothelioma malignant – Treatment Leiomyosarcoma – Treatment VEXAS syndrome – Diagnostics Synovial sarcoma – Treatment Glycogen storage disease type I Methylmalonic acidaemia Bronchiolitis obliterans syndrome – Treatment Aicardi-Goutieres syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ABIRATERONE DECANOATE Art6043 Gallium (68Ga) Chloride (-)-PHENSERINE TARTRATE Fenofibrate Micronised Cd7-Cart01 Tofacitinib Rineterkib PAPAVERINE HYDROCHLORIDE Lixudebart TRONTINEMAB Etanercept Cobamamide METHYLPHENIDATE Neomycin Sulfate Bnt314 HTL0022537 Hydralazine Hydrochloride H2-Receptor Antagonist Relebactam More therapies…

    Learn about Your Condition

    Hereditary angioedema Hepatotoxicity Thymoma malignant Hepatorenal syndrome K-ras gene mutation Endometrial cancer metastatic Niemann-Pick disease Ischaemic stroke Hyperphagia Corneal graft rejection Injury Follicular lymphoma stage III Cardiac valve disease Ewing's sarcoma metastatic Cardiac amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Schizophrenia

  • Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Croatia Czechia France Germany Hungary +3

  • Study on the Effects of GT-002 and Oxazepam for Cognitive Impairment in Schizophrenia Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Schizoaffective disorder
    • Psychotic disorder
    • Schizophrenia
    Investigated Drugs:
    • GT-002
    • Oxazepam
    Denmark

  • Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

    Recruiting

    4 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Schizoaffective disorder
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark

  • Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    • Schizophrenia
    Investigated Drugs:
    • Tirzepatide
    • Sodium Chloride
    Denmark

  • Study on Sodium Benzoate and Clozapine for Adults with Refractory Schizophrenia Symptoms

    Recruiting

    4 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • SODIUM BENZOATE
    Poland
Previous Page
1 2 3 4 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!